INDOLENT MANTLE CELL LYMPHOMA

Clinical trials for INDOLENT MANTLE CELL LYMPHOMA explained in plain language.

Never miss a new study

Get alerted when new INDOLENT MANTLE CELL LYMPHOMA trials appear

Sign up with your email to follow new studies for INDOLENT MANTLE CELL LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New combo aims to control Slow-Growing blood cancer without chemo

Disease control Not yet recruiting

This study tests a three-drug combination (pomalidomide, an anti-CD20 antibody, and prednisone) as a first treatment for people with slow-growing B-cell lymphomas. About 30 adults who have not had prior treatment will receive six cycles of the drugs, followed by two years of main…

Matched conditions: INDOLENT MANTLE CELL LYMPHOMA

Sponsor: The First Affiliated Hospital of Soochow University • Aim: Disease control

Last updated Jun 16, 2026 12:49 UTC

INDOLENT MANTLE CELL LYMPHOMA

Get alerted when new INDOLENT MANTLE CELL LYMPHOMA trials appear

New combo aims to control Slow-Growing blood cancer without chemo